Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Masamichi Abe"'
Autor:
Akira Hanazono, Masamichi Abe, Shuntaro Togashi, Teruko Takahashi, Naoto Takahashi, Masashiro Sugawara
Publikováno v:
Frontiers in Stroke, Vol 3 (2024)
While tyrosine kinase inhibitors (TKI)-associated cerebral vascular stenosis (CVS) exhibit distinct mechanisms compared to conventional stroke in basic research, the clinical strategy remains nearly the same other than TKI-switching. We present the c
Externí odkaz:
https://doaj.org/article/e6b9f6454d7640ec93ed1e2cb92df1ff
Autor:
Kayoko Matsunaga, Akiko Yagami, Seiji Hasegawa, Hirohiko Akamatsu, Masayuki Takahashi, Masaru Arima, Yohei Iwata, Masamichi Abe, Shiroh Ohgo, Satoru Nakata, Hiroshi Mizutani
Publikováno v:
The Journal of Dermatology. 40:720-725
Morphea is a type of localized scleroderma. It is a skin disease involving the development of fibrosis in the dermis and subcutaneous fat tissue beneath without a visceral lesion, and the cause is still unclear. An involvement of epithelial-mesenchym
Autor:
Masayuki TAKAHASHI, Yohei IWATA, Masaru ARIMA, Masamichi ABE, Ryosuke SASAKI, Kyoko TSURUTA, Masanori HISAOKA, Makoto KURODA, Kayoko MATSUNAGA
Publikováno v:
Skin Cancer. 27:339-344
Autor:
Chie Sotozono, Michiko Aihara, R Hasegawa, Mayumi Ueta, Zenro Ikezawa, Masamichi Abe, Shigeru Kinoshita, Masahiro Tohkin, Yoshiro Saito, Kouichi Kurose, Masaaki Muramatsu, Hirokazu Furuya, Yukitoshi Takahashi, Kayoko Matsunaga, E Sugiyama, Jun Nishikawa, H Ikeda, Nahoko Kaniwa
Publikováno v:
The Pharmacogenomics Journal. 13:60-69
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are severe, cutaneous adverse drug reactions that are rare but life threatening. Genetic biomarkers for allopurinol-related SJS/TEN in Japanese were examined in a genome-wide associati
Autor:
Kayoko Suzuki, Masaru Arima, Masamichi Abe, Naoki Sugaya, Keiko Hirokawa, Rina Kameyama, Yatsuka Hibi, Kayoko Matsunaga
Publikováno v:
Skin Cancer. 26:210-214
Autor:
Hirokazu Furuya, Ryuichi Hasegawa, Yixuan Song, Kayoko Matsunaga, Hiroko Ikeda, Shigeru Kinoshita, Mayumi Ueta, Mariko Kashiwagi, Yoshiro Saito, Yukitoshi Takahashi, Nahoko Kaniwa, Kouichi Kurose, Zenro Ikezawa, Masamichi Abe, Masaaki Muramatsu, Masahiro Tohkin, Chie Sotozono, Michiko Aihara
Publikováno v:
Epilepsia. 51:2461-2465
Summary Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threatening severe cutaneous adverse reactions. Recently, strong associations of HLA-B*1502 with carbamazepine-induced SJS/TEN have been found in Han Chines
Autor:
Masayuki Takahashi, Kayoko Matsunaga, Masaru Arima, Akiyo Sano, Yoshikazu Mizoguchi, Toshiaki Utsumi, Masamichi Abe
Publikováno v:
Skin Cancer. 25:33-37
Autor:
Hiroaki Iwata, Akifumi Yamamoto, Masamichi Abe, Yuya Murata, Naoya Yamazaki, Kenjiro Namikawa, Hidenori Ojima, Koji Yoshino, Hisatoshi Yoshida, Akira Takahashi, Aya Nishizawa
Publikováno v:
Skin Cancer. 21:199-205
乳房外パジェット病は多くの場合表皮内癌として緩徐に進行する一方で, 一度転移を来した例では治療に難渋し, その多くは腫瘍死することとなる。今回, 後者のような進行期乳房外パジ
Autor:
Masamichi Abe, Noriyoshi Yuge, Shoichi Hiwasa, Hiroyuki Baba, Yasuhiko Sakaguchi, Nakamura Naomichi, Fukuo Aratani, Yoshiei Kato, Kazuhiro Hanazawa
Publikováno v:
Progress in Photovoltaics: Research and Applications. 9:203-209
An estimate has been made of the feasibility of a metallurgical purification process, the NEDO (New Energy and Industrial Technology Development Organization) melt-purification process, for manufacturing solar-grade silicon from metallurgical-grade s
Autor:
Masahiro Tohkin, Ryuichi Hasegawa, Keiko Maekawa, Yukitoshi Takahashi, Yoshiro Saito, Kayoko Matsunaga, Chie Sotozono, Michiko Aihara, Taisei Mushiroda, Kouichi Kurose, Naoyuki Kamatani, Shigeru Kinoshita, Hiroko Ikeda, Takeshi Ozeki, Michiaki Kubo, Masamichi Abe, Hirokazu Furuya, Zenro Ikezawa, Mayumi Ueta, Emiko Sugiyama, Akiko Yagami, Masaaki Muramatsu, Nahoko Kaniwa
Publikováno v:
Pharmacogenomics. 14(15)
Aim: This preliminary study investigated genomic biomarkers for Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), related to three antiepileptic drugs, zonisamide, phenobarbital and phenytoin. Patients & methods:HLA class I and H